Tear Sheet

Tear Sheet

Corporate Profile

We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Stock Chart

Copyright Nasdaq. Minimum 15 minutes delayed.

Stock Quote

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet